Back to Search
PRIMO LARA, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1972585743IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
A55072(CA)
Education
OTHER
Class of 1992
Research & Publications (20)
Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124.
PMID 19349543·J Clin Oncol·2009
3-trial
A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study.
PMID 19396016·Anticancer Drugs·2009
3-trial
Predictors of survival of advanced renal cell carcinoma: long-term results from Southwest Oncology Group Trial S8949.
PMID 19100570·J Urol·2009
4-observational
Disease control rate at 8 weeks predicts clinical benefit in advanced non-small-cell lung cancer: results from Southwest Oncology Group randomized trials.
PMID 18202421·J Clin Oncol·2008
4-observational
Bortezomib (PS-341) in relapsed or refractory extensive stage small cell lung cancer: a Southwest Oncology Group phase II trial (S0327).
PMID 17409985·J Thorac Oncol·2006
3-trial
Bortezomib plus docetaxel in advanced non-small cell lung cancer and other solid tumors: a phase I California Cancer Consortium trial.
PMID 17409841·J Thorac Oncol·2006
3-trial
Randomized phase III trial of cisplatin/irinotecan versus cisplatin/etoposide in patients with extensive-stage small-cell lung cancer.
PMID 16640809·Clin Lung Cancer·2006
3-trial
A randomized phase II trial of the matrix metalloproteinase inhibitor BMS-275291 in hormone-refractory prostate cancer patients with bone metastases.
PMID 16533781·Clin Cancer Res·2006
3-trial
Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials.
PMID 16361626·J Clin Oncol·2005
8-other
Proteasome inhibition in small-cell lung cancer: preclinical rationale and clinical applications.
PMID 16250931·Clin Lung Cancer·2005
6-review
The cyclin-dependent kinase inhibitor UCN-01 plus cisplatin in advanced solid tumors: a California cancer consortium phase I pharmacokinetic and molecular correlative trial.
PMID 15958629·Clin Cancer Res·2005
3-trial
Intermittent dosing of the farnesyl transferase inhibitor tipifarnib (R115777) in advanced malignant solid tumors: a phase I California Cancer Consortium Trial.
PMID 15711184·Anticancer Drugs·2005
3-trial
Gemcitabine in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: a phase II California cancer consortium trial.
PMID 15476595·Clin Lung Cancer·2004
3-trial
Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial.
PMID 15139054·Cancer·2004
3-trial
Proteasome inhibition with PS-341 (bortezomib) in lung cancer therapy.
PMID 14981579·Semin Oncol·2004
6-review
Trastuzumab plus docetaxel in HER2/neu-positive non-small-cell lung cancer: a California Cancer Consortium screening and phase II trial.
PMID 14967075·Clin Lung Cancer·2004
3-trial
Platinum-free combination chemotherapy in patients with advanced or metastatic transitional cell carcinoma.
PMID 14692027·Cancer·2004
3-trial
SU5416 plus interferon alpha in advanced renal cell carcinoma: a phase II California Cancer Consortium Study with biological and imaging correlates of angiogenesis inhibition.
PMID 14581348·Clin Cancer Res·2003
3-trial
Tirapazamine plus carboplatin and paclitaxel in advanced malignant solid tumors: a california cancer consortium phase I and molecular correlative study.
PMID 14555506·Clin Cancer Res·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2279 45TH STREET
SACRAMENTO, CA 95817 - Phone
- (916) 734-5959
Quick Facts
- NPI
- 1972585743
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 34
- Publications
- 20
Are you this provider?
Claim Your Profile